WASHINGTON (CN) - The Food and Drug Administration has issued a regulation requiring hospitals and blood banks to establish a system to identify blood and components previously donated by a person whose later blood donation tests positive for hepatitis C. The hepatitis C may be found by testing, reviewing records, or other reliable means. Since the donor's blood may transmit hepatitis C, the FDA requires collectors to quarantine any of the donor's unexpired blood, and notify centers that received the blood to quarantine it and test the donor. Centers that have used the blood in transfusions must notify recipients. The regulation also changes the human immunodeficiency virus rules to be consistent with the new hepatitis C rules. for details and other new regulations.
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.
Additional Reads
-
Alaska, Hawaiian Airlines April 17, 2024 -
-
Contributor-Test-Post-2024-04-12 April 12, 2024 -
